Aug 2023 $1 M No. 5 Under $2 million 1
Provell Pharmaceuticals, LLC: Raise no. 5, Aug 2023 × Investors in this round 1 investor had bought by the notice of Aug 15, 2023: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, other: Convertible Note that converts into membership interest of Issuer in accordance with the terms therein. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Pennsylvania People named in the notice James G. Small · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Mr. Small will be entitled to fees for his services as Manager of Issuer in such amounts as may be approved by the Board of the Issuer. However, no one will receive any sales commission or finders fees in connection with this offering.”Signed by James G. Small, Manager. Source: SEC Form D, newest notice filed Aug 15, 2023. Read the notice at the SEC .
debt, options SEC Mar 2023 $2 M No. 4 $2 to $10 million 1
Provell Pharmaceuticals, LLC: Raise no. 4, Mar 2023 × Investors in this round 1 investor had bought by the notice of Mar 28, 2023: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Pennsylvania People named in the notice James G. Small · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Mr. Small will be entitled to fees for his services as Manager of Issuer in such amounts as may be approved by the Board of the Issuer. However, no one will receive any sales commission or finders fees in connection with this offering.”Signed by James G. Small, Manager. Source: SEC Form D, newest notice filed Mar 28, 2023. Read the notice at the SEC .
equity SEC Jun 2022 $2 M No. 3 $2 to $10 million 1
Provell Pharmaceuticals, LLC: Raise no. 3, Jun 2022 × Investors in this round 1 investor had bought by the notice of Jul 11, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Pennsylvania People named in the notice James G Small · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Mr. Small will be entitled to fees for his services as Manager of Issuer in such amounts as may be approved by the Board of the Issuer. However, no one will receive any sales commission or finders fees in connection with this offering.”Signed by James G. Small, Manager. Source: SEC Form D, newest notice filed Jul 11, 2022. Read the notice at the SEC .
equity SEC Jun 2019 $2 M No. 2 $2 to $10 million 1
Provell Pharmaceuticals, LLC: Raise no. 2, Jun 2019 × Investors in this round 1 investor had bought by the notice of Jul 10, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Pennsylvania People named in the notice James G. Small · Executive Officer · Manager, President and Chief Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Mr. Small will be entitled to fees for his services as Manager of Issuer in such amounts as may be approved by the Board of the Issuer. However, no one will receive any sales commissions or finders fees in connection with this Offering.”Signed by James G. Small, Manager. Source: SEC Form D, newest notice filed Jul 10, 2019. Read the notice at the SEC .
equity SEC Oct 2013 $5 M No. 1 $2 to $10 million 1
Provell Pharmaceuticals, LLC: Raise no. 1, Oct 2013 × Investors in this round 1 investor had bought by the notice of Dec 3, 2013: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Limited Liability Company, incorporated in Pennsylvania People named in the notice James G. Small · Executive Officer · Manager, President, and Chief Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Mr. Small will be entitled to fees for his services as Manager of Issuer in such amounts as may be approved by the Board of Issuer.”Signed by James G. Small, Manager. Source: SEC Form D, newest notice filed Dec 3, 2013. Read the notice at the SEC .
equity SEC